EVP, General Counsel, Corp Sec
Mon, Mar 11, 2024
Mar 11
exercised or converted securities in ANIK
7,662 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +75.60% (+11,873 shares)
ANIKAnika Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W-1.07%
1M+42.74%
3M+44.09%
6M—
1Y—